.RESEARCH HIGHLIGHT.06 August 2024.
A huge randomized regulated test with cisgender girls highlights the obstacles of faithfulness to a daily oral preexposure treatment routine as well as shows that twice-yearly injection of lenacapavir can preserve reliable HIV avoidance amounts over 6 months.